World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
73
Citations
20110
World Ranking
4930
National Ranking
1542

Barbara S. Slusher publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Barbara S. Slusher sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 304 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Barbara S. Slusher D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Barbara S. Slusher sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 73 D-Index — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Barbara S. Slusher is affiliated with Johns Hopkins University School of Medicine in the United States. Their research spans multiple disciplines, primarily within biochemistry, genetics, and molecular biology, alongside medicine. The body of their work includes a significant focus on molecular biology, neurology, immunology, physiology, and cancer research.

The main scientific topics addressed in their research include cancer, hypoxia, and metabolism; neuroinflammation and neurodegeneration mechanisms; extracellular vesicles in disease; immune cells in cancer; epigenetics and DNA methylation; sphingolipid metabolism and signaling; and cancer research and treatments.

Slusher's publications appear frequently in prominent venues where they have contributed extensively. The most common journals and platforms include bioRxiv (Cold Spring Harbor Laboratory), the Journal of Medicinal Chemistry, Cancer Research, Gastroenterology, and Neurotherapeutics.

Frequent collaborators in the research by Slusher include Rana Rais, Ajit G. Thomas, Jesse Alt, Takashi Tsukamoto, and Lukáš Tenora. These coauthors have contributed to multiple projects alongside Slusher, signaling sustained collaborative relationships.

Among recent scientific papers associated with Barbara S. Slusher are the following:

  • "Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells" (2020, Journal of Clinical Investigation)
  • "Characterization of extracellular vesicles and synthetic nanoparticles with four orthogonal single-particle analysis platforms" (2021, Journal of Extracellular Vesicles)
  • "Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug" (2022, Science Advances)
  • "Targeting Glutamine Metabolism to Enhance Immunoprevention of EGFR-Driven Lung Cancer" (2022, Advanced Science)
  • "Phosphonates and Phosphonate Prodrugs in Medicinal Chemistry: Past Successes and Future Prospects" (2022, Frontiers in Chemistry)

Best Publications

  • Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis

    Scott J Dixon;Darpan N Patel;Matthew Welsch;Rachid Skouta

  • Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells

    Anne Le;Andrew N. Lane;Max Hamaker;Sminu Bose

  • Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion

    Robert D. Leone;Liang Zhao;Judson M. Englert;Im Meng Sun

  • Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1.

    Meghan J. Seltzer;Bryson D. Bennett;Avadhut D. Joshi;Ping Gao

  • Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis

    Yan Xiang;Zachary E. Stine;Jinsong Xia;Yunqi Lu

  • Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells

    Min Hee Oh;Im Hong Sun;Liang Zhao;Robert D. Leone

  • Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury.

    Barbara S. Slusher;James J. Vornov;Ajit G. Thomas;Patricia D. Hurn

  • Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients with Metastatic Prostate Cancer

    Steve Y. Cho;Kenneth L. Gage;Ronnie C. Mease;Srinivasan Senthamizhchelvan

  • Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer.

    Jeroen R Mesters;Cyril Barinka;Weixing Li;Takashi Tsukamoto

  • Design, synthesis, and biological activity of a potent inhibitor of the neuropeptidase N-acetylated α-linked acidic dipeptidase

    Paul F. Jackson;Derek C. Cole;Barbara S. Slusher;Susan L. Stetz

  • Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor.

    Camilo Rojas;Marigo Stathis;Ajit G. Thomas;Edward B. Massuda

  • Glutamate Carboxypeptidase II in Diagnosis and Treatment of Neurologic Disorders and Prostate Cancer

    C. Bařinka;C. Rojas;B. Slusher;M. Pomper

  • Design, synthesis, and pharmacological evaluation of bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide 3 (BPTES) analogs as glutaminase inhibitors.

    Krupa Shukla;Dana V. Ferraris;Ajit G. Thomas;Marigo Stathis

  • Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer

    Amira Elgogary;Qingguo Xu;Brad Poore;Jesse Alt

  • We're Not "DON" Yet: Optimal Dosing and Prodrug Delivery of 6-Diazo-5-oxo-L-norleucine.

    Kathryn M. Lemberg;James J. Vornov;James J. Vornov;Rana Rais;Barbara S. Slusher

  • Palonosetron triggers 5-HT3 receptor internalization and causes prolonged inhibition of receptor function

    Camilo Rojas;Ajit G. Thomas;Jesse Alt;Marigo Stathis

  • Characterization of extracellular vesicles and synthetic nanoparticles with four orthogonal single‐particle analysis platforms

    Tanina Arab;Emily R. Mallick;Yiyao Huang;Liang Dong

  • Molecular mechanisms of 5-HT3 and NK1 receptor antagonists in prevention of emesis

    Camilo Rojas;Mithun Raje;Takashi Tsukamoto;Barbara S. Slusher

  • Immunocytochemical localization of the N-acetyl-aspartyl-glutamate (NAAG) hydrolyzing enzyme N-acetylated α-linked acidic dipeptidase (NAALADase)

    Barbara Stauch Slusher;Guochuan Tsai;Grace Yoo;Joseph T. Coyle

  • Rat brain N-acetylated alpha-linked acidic dipeptidase activity. Purification and immunologic characterization.

    B S Slusher;M B Robinson;G Tsai;M L Simmons

  • In vitro and In vivo Radiosensitization of Glioblastoma Cells by the Poly (ADP-Ribose) Polymerase Inhibitor E7016

    Andrea L. Russo;Hyuk-Chan Kwon;William E. Burgan;William E. Burgan;Donna Carter;Donna Carter

Frequent Co-Authors

Jonathan D. Powell
Jonathan D. Powell Johns Hopkins University School of Medicine
Norman J. Haughey
Norman J. Haughey Tulane University
Charles G. Eberhart
Charles G. Eberhart Johns Hopkins University School of Medicine
Jan Konvalinka
Jan Konvalinka Czech Academy of Sciences
Amy Hauck Newman
Amy Hauck Newman National Institutes of Health
Martin G. Pomper
Martin G. Pomper Johns Hopkins University School of Medicine
David J. Volsky
David J. Volsky Icahn School of Medicine at Mount Sinai
Joseph T. Coyle
Joseph T. Coyle Harvard University
Guido Cavaletti
Guido Cavaletti University of Milano-Bicocca
Zheng-Xiong Xi
Zheng-Xiong Xi National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to numerous career paths that blend science with practical applications. Many students pursue degrees that lead to roles in healthcare, pharmaceuticals, forensic science, and legal support. Understanding these pathways can help guide your education and career planning.

For those interested in healthcare and pharmaceuticals, becoming a pharmacist requires extensive education. If you want to learn about how much schooling to be a pharmacist, this is a critical consideration before committing to this rewarding but demanding profession.

On the other hand, a career as a pharmaceutical sales representative offers a more business-oriented role within the scientific field. Curious about earning potential in this area? Exploring the pharmaceutical rep salary can provide insight into the benefits and expectations of this pathway.

Chemistry graduates can also contribute to forensic and legal settings. For instance, becoming an autopsy technician involves specialized training. Examining the autopsy tech salary and job outlook helps evaluate if this role matches your interests and lifestyle goals.

Another intriguing option involves legal support roles tied to scientific knowledge. Discovering what types of paralegals make the most money, especially those with science backgrounds, can open unexpected career opportunities.

Best Scientists Citing Barbara S. Slusher

Trending Scientists

Recently Published Articles